NCT05287464 2025-11-26
International Multicentric Study ARON-1
Hospital of Macerata
Recruiting
Clinical Trials
6 trialsNCT06345183 2025-11-06
Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients
Bristol-Myers Squibb
Completed
NCT04682587 2025-01-03
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
Pfizer
Completed
NCT04555603 2023-11-21
Axitinib Therapy Management Study
Pfizer
Withdrawn
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT03695835 2020-07-22
NIRPA
Gary Onik MD
Completed